ESMO Immuno-Oncology Congress 2022

Resources are available according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

Abstracts and ePosters are open access. Slides and webcasts are reserved to registered Delegates and ESMO Members.

From the basics of immunotherapies to the latest research results; from understanding different treatment options to the management of toxicities and interpretation of new data, the ESMO Immuno-Oncology Congress caters to the diverse needs of oncology stakeholders with an interest in this topical field of cancer treatment.

Learning objectives

• Update your knowledge on the fast-developing field of cancer immunotherapy
• Review state-of-the-art in novel diagnostics, biomarkers and therapeutic strategies in immune-oncology
• Understand recent developments on immune modulation, including tumour microenvironment, immunometabolism, epigenetics or microbiome
• Update your knowledge on novel immune-oncology strategies including immune-cells therapies, multi-specific antibodies, oncolytic virus or cancer vaccines
• Be informed on emerging evidence and research on immunotherapies in combination with other anti-cancer targeted therapies